The clinical trial, conducted in J.B. Roy State Ayurvedic Medical College & Hospital – Dept. of Health & Family Welfare (AYUSH), Govt. of W.B. The West Bengal University of Health Sciences (Affiliated)<\/strong>, focused on post-surgery breast cancer patients undergoing chemotherapy and radiotherapy. The randomized, case-control study lasted starting from 1st<\/sup> October 2023 to 30th<\/sup> November 2024 <\/strong>and included 44 participants. It aimed to evaluate Body Revival`s ability to improve quality of life (QoL)<\/strong> and progression-free survival (PFS),<\/strong> while also counteracting the adverse side effects of chemotherapy and radiotherapy.<\/p>\n The results were extraordinary. Body Revival significantly enhanced physical stamina, appetite, and psychological well-being<\/strong>. It reduced common side effects such as nausea, fatigue, and dizziness. Remarkably, it also lowered the breast cancer biomarker CA-15.3, which indicates tumor activity. Additionally, patients showed improved levels of hemoglobin, white blood cells, and neutrophils, highlighting its immunomodulatory effects<\/strong>.<\/p>\n Speaking about this achievement, Mr. Munish Khan, CEO of Health Reactive<\/strong>, stated, “This is a proud moment for us and a leap forward for Ayurveda as a globally respected science. Body Revival embodies our vision of ‘Futuristic Ayurveda,’ blending ancient Ayurvedic knowledge with modern clinical standards. This makes us India’s first company to validate Ayurveda through human trials.”<\/em><\/p>\n Body Revival, crafted from nine research-backed natural Ingredients<\/strong>, including Ashwagandha, Manjishtha, and Indian Bael, works on the principles of immunotherapy<\/strong>. It boosts the immune system, detoxifies the body, and repairs damaged cells, paving the way for holistic cancer management. With 100% natural ingredients<\/strong> and no reported side effects, Body Revival offers a safe and effective complementary approach to conventional cancer treatments.<\/p>\n This trial reaffirms Ayurveda`s immense potential in improving cancer care. The study demonstrated how combining Ayurvedic interventions like Body Revival with chemotherapy and radiotherapy could alleviate side effects, improve overall well-being, and contribute to disease-free longevity<\/strong>. The findings were presented at the prestigious 10th International World Ayurveda Congress in Dehradun<\/strong>, further validating India’s leading role in Ayurvedic research.<\/p>\n Health Reactive’s<\/a> visionary leadership under Mr. Munish Khan<\/strong> ensures that Ayurveda is no longer viewed as just traditional medicine but as a science that can contribute to global healthcare advancements. This initiative underscores their commitment to pioneering Futuristic Ayurveda<\/strong>, where innovation and ancient knowledge come together to offer effective solutions for today’s health challenges. <\/p>\n As the first-ever Ayurvedic Human clinical trial on cancer patient in India<\/strong>, the Body Revival study sets a new benchmark for the industry, inspiring others to embrace evidence-based research. Health Reactive has not only cemented its position as a trailblazer in Ayurvedic innovation but has also instilled hope for millions battling breast cancer.<\/p>\n![\"\"](\"http:\/\/origin.mid-day.com\/images\/2025\/feb\/munish-04021.1_e.jpg\")
<\/p>\n![\"\"](\"http:\/\/origin.mid-day.com\/images\/2025\/feb\/munish-04021.2_e.jpg\")
<\/p>\n